Creo Medical Group plc (CMEOF)
Market Closed
2 Jun, 13:31
OTC PINK 
$
0. 20
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
2,500 Volume
- Eps
$ 0.2
Previous Close Want to track CMEOF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
CMEOF closed yesterday higher at $0.2, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, CMEOF stock gained 0%.
CMEOF is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XSTU (EUR).
CMEOF Chart
Creo Medical Group plc (CMEOF) FAQ
What is the stock price today?
The current price is $0.20.
On which exchange is it traded?
Creo Medical Group plc is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is CMEOF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Creo Medical Group plc ever had a stock split?
No, there has never been a stock split.
Creo Medical Group plc Profile
| Health Care Technology Industry | Healthcare Sector | Mr. Craig Jonathan Gulliford CEO | OTC PINK Exchange | - ISIN |
| United Kingdom Country | 278 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Creo Medical Group PLC is a pioneering company focused on the research, development, manufacturing, and sale of medical devices and instruments within the United Kingdom. Founded in 2003 and headquartered in Chepstow, the company is at the forefront of innovating medical technologies, notably in the realm of minimally invasive procedures. Its flagship energy platform, CROMA, integrates bipolar radiofrequency with microwave energy to enhance surgical precision and control, all delivered through a flexible endoscope. This dual-energy approach facilitates both precise cutting and controlled coagulation, marking a significant advance in medical procedure technology.
Products and Services
- Speedboat Inject - An innovative energy multimodal instrument designed for use in flexible endoscopy, offering enhanced capabilities for endoscopic surgeries.
- MicroBlate Fine - A compact microwave needle ablation device intended for targeted tissue ablation with minimal invasiveness.
- MicroBlate Flex - This expands on the MicroBlate series with a flexible design for soft tissue ablation, promoting versatility in medical procedures.
- SlypSeal Flex - A state-of-the-art flexible haemostasis device, crucial for treating upper and lower gastrointestinal bleeds with precision and effectiveness.
- SpydrBlade Flex - A novel flexible bipolar RF and microwave scissor device that seamlessly integrates grasping, cutting, and coagulation of highly perfused tissues, illustrating a leap forward in surgical efficiency.
- Endotherapy Accessories
- ScopeSnare - An energy-based polypectomy snare, enhancing the safety and efficacy of polypectomy procedures.
- ScopeSnare Cold - Provides a cutting wire designed for the endoscopic removal of various types of polyps and tissues within the GI tract, emphasizing minimally invasive techniques.
- ScopeClip - A single-use, rotational and repositionable hemoclip designed for precise hemostasis.
- ScopeBite - A comprehensive portfolio of biopsy forceps, tailored for varying diagnostic requirements.
- ScopeGrasp - Offers a range of grasping forceps, ensuring reliability and precision in tissue manipulation during procedures.
- ScopeInject - An injection needle complementing the endotherapy range, designed for preciseness in substance delivery to targeted tissues.
Contact Information
Address: Creo House
Phone: 44 12 9160 6005
Website: https://www.creomedical.com
